Ultrafast Microscope Camera
| Location: | Maryland |
|---|---|
| Posted: | Aug 5, 2026 |
| Due: | Aug 14, 2026 |
| Agency: | COMMERCE, DEPARTMENT OF |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | 1333ND26QNB640413 |
| Publication URL: | To access bid details, please log in. |
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
- Original Published Date: Aug 04, 2026 10:49 pm EDT
- Original Date Offers Due: Aug 14, 2026 11:00 am EDT
- Inactive Policy: 15 days after date offers due
- Original Inactive Date: Aug 29, 2026
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: 6650 - OPTICAL INSTRUMENTS, TEST EQUIPMENT, COMPONENTS AND ACCESSORIES
-
NAICS Code:
- 334516 - Analytical Laboratory Instrument Manufacturing
-
Place of Performance:
Gaithersburg , MD 20899USA
The gene therapy manufacturing innovations in measurement sciences (IMS) project, in the Biosystems and Biomaterials Division, within the Material Measurement Laboratory of the National Institute of Standards and technology, pursues the goal of developing light scattering microscopy methods to characterize gene delivery particles. Emerging gene therapy treatments use gene delivery nanoparticles, such as viral vectors and non-viral carriers, to cure intractable diseases. These manufactured particles suffer heterogeneity issues that hinder treatment efficacy and safety. This project aims to develop light-scattering microscopy methods to enable rapid, multi-attribute measurements of individual gene therapy nanoparticles’ physical characteristics. Such measurements will speed the development of new gene therapy treatments and improve their efficacy and safety.
- ACQUISITION MANAGEMENT DIVISION 100 BUREAU DR.
- GAITHERSBURG , MD 20899
- USA
- Rene D. Edwards
- rene.edwards@nist.gov
- Phone Number 3019756107
- Robert Singman
- robert.singman@nist.gov
- Phone Number 3019756388
- Aug 04, 2026 10:49 pm EDTCombined Synopsis/Solicitation (Original)
With GovernmentContracts, you can:
- Find more opportunities and win more business
- Receive daily alerts for all new bid opportunities
- Get contract opportunities matched to your business
See also
...Ultra-rare Gene-based Therapy (URGenT) Network Active Contract Opportunity Notice ID 7571PS27Q00015... for the ...
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 11/02/2026
...equipment used in manufacturing patient-specific cellular therapies for patients enrolled... in clinical trials ...
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 11/04/2026
...to determine if post-operative corticosteroid therapy improves serum bilirubin and survival without liver... ...
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 5/31/2029
...therapy (including via AAV9 vectors), and pediatric as well as adult populations, as ...
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 11/13/2026